Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
KURA — Kura Oncology, Inc.
NASDAQ
FULL STOCK PAGE →

Q1 2026 Earnings Call Summary

MAY 12, 2026
REVENUE
$18.3M +5.4%
NET MARGIN
-401.5% +65.7 PTS
EPS
-$0.83 +9.8%
FREE CASH FLOW
-$86.0M -174.8%

No summary has been written for this call yet.